GSK256471
GSK256471 is a non-peptide tachykinin NK3 receptor antagonist with a pKi of 8.9 for the human recombinant NK3 receptor and 8.4 for the guinea pig native receptor. GSK256471 exhibits >100-fold selectivity for NK1 (pKi = 5.2) and NK2 (pKi = 7.3) receptors. GSK256471 noncompetitively inhibits neurokinin B (NKB) -induced inositol phosphate accumulation, and this inhibition is irreversible. GSK256471 inhibits wet dog shaking behavior and suppresses dopamine release. GSK256471 could be used to study schizophrenia[1][2].
Product Specifications
CAS Number
1133706-08-7
UNSPSC
12352005
Target
Neurokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
O=C(N[C@H](C1=CC=CC=C1)C2CC2)C3=C(C(C4=CC=CC=C4)=NC5=CC=CC=C35)CN(S(=O)(C)=O)C
Molecular Formula
C29H29N3O3S
Molecular Weight
499.62
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NK3R
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
CD45RB (B-Cell Marker) (rPTPRC/1132), CF640R conjugate, 0.1mg/mL
Desmocollin-2/3 (rDSC2/3437), CF405S conjugate, 0.1mg/mL
